Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Industry News

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

September 25, 2017

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

News Conference News TVT 2017

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Shelley Wood

June 15, 2017

News Daily News

Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease

L.A. McKeown

June 12, 2017

News Conference News

Mixed Results, With Some Promising Data, in Heart Failure Destination Therapy Trial

Todd Neale

April 07, 2017

News Conference News ACC 2017

My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time

Shelley Wood

March 23, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2017

Caitlin E. Cox

February 01, 2017

Advertisement

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease

Mixed Results, With Some Promising Data, in Heart Failure Destination Therapy Trial

My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

TCTMD’s Top 10 Most Popular Stories for January 2017

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content